X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Approves Sanofis Wayrilz

    FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

    DAWNZERA for Hereditary Angioedema

    U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

    Major Depressive Disorder

    AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

    FDA Approved Papzimeos

    The U.S. FDA Approved Papzimeos for RRP Treatment in Adults

    Biosimilar Ranibizumab

    Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab

    FDA Approves Brinsupri by Insmed for Chronic Lung Condition

    FDA Approves Brinsupri by Insmed for Chronic Lung Condition

    FDA Approves Brain Tumour Treatment Modeyso by Jazz Pharma

    FDA Approves Brain Tumour Treatment Modeyso by Jazz Pharma

    Thermo Fisher New HMW Kit Powers Long Read DNA Sequencing

    Thermo Fisher New HMW Kit Powers Long-Read DNA Sequencing

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Approves Sanofis Wayrilz

    FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

    DAWNZERA for Hereditary Angioedema

    U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

    Major Depressive Disorder

    AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

    FDA Approved Papzimeos

    The U.S. FDA Approved Papzimeos for RRP Treatment in Adults

    Biosimilar Ranibizumab

    Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab

    FDA Approves Brinsupri by Insmed for Chronic Lung Condition

    FDA Approves Brinsupri by Insmed for Chronic Lung Condition

    FDA Approves Brain Tumour Treatment Modeyso by Jazz Pharma

    FDA Approves Brain Tumour Treatment Modeyso by Jazz Pharma

    Thermo Fisher New HMW Kit Powers Long Read DNA Sequencing

    Thermo Fisher New HMW Kit Powers Long-Read DNA Sequencing

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

    Taiwan Grants Full Approval for NEFECON IgAN Treatment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

API PA by API PA
30th August 2025
in Packaging & Logistic, Press Statements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

  • The highest flexibility regarding products, containers, and closures
  • Half the footprint thanks to exchangeable modules and a high degree of automation
  • Identical machine base, easy format changeovers, and gentle transport

Waiblingen, August 28, 2025. Rotzinger PharmaPack is launching a new filling and capping platform for over-the-counter (OTC) products such as non-aseptic pharmaceuticals as well as solid and liquid products from the cosmetics, personal care, and nutraceutical industries. VarioFill combines the advantages of previously large lines on a compact and modular platform: “Where manufacturers and contract fillers previously needed new machines for different products and closures, VarioFill now enables them to process everything on a single platform – from non-aseptic pharmaceutical liquids such as eye drops and cough syrup to cosmetics such as creams and face serums to solid dosage forms such as tablets and capsules. Added to this are different packaging materials and shapes as well as various closure types in highly variable output quantities,” explains Michael Gensheimer, Product Manager at Rotzinger PharmaPack.

More than 50 percent space savings thanks to modular design

Among the many advantages of the VarioFill platform is its small footprint. “In fact, VarioFill is currently the most space-saving solution of its kind on the market,” Gensheimer underlines. Thanks to a high degree of automation and exchangeable modules, space savings even exceed 50 percent. “With VarioFill, modularity is much more than just a buzzword; it’s a daily reality.” This is particularly beneficial in the case of frequent product changes. The machine base, which is identical for all variants, allows new stations and modules to be installed. “All you need to do is reconfigure the platform with the appropriate modules, and the line is ready for new requirements at low investment costs,” says Gensheimer.

Gentle transport and 100 percent IPC

Before filling, the containers are fed into the transport system. Different solutions can be integrated and combined as required. Standing objects such as glass bottles are fed via a belt system, while the pickFeeder developed by Rotzinger sorts plastic bottles and transfers via delta robots. Since the magnetically driven universal grippers can handle almost any shape, there is no need for pucks or other guiding format parts, which makes transport particularly gentle.

After the cleaning station, the containers are weighed empty using 100% in-process control (IPK). Following filling via sealless rotary piston pumps or tablet or capsule counters, another IPC is performed. The containers are fitted with snap-on, screw, pump, or crimp closures at several freely configurable closure stations. A cleaning-in-place (CIP) system ensures fully automatic cleaning of product contact parts in the filling area by automatically moving them to the cleaning position, cleaning them thoroughly, and then returning them to the production position.

First customers already convinced

The very positive customer feedback shows that Rotzinger PharmaPack’s innovative solution meets the needs of manufacturers and contract fillers in all relevant industries: “The response from the pharmaceutical, cosmetics, and nutraceutical industries has been overwhelming. Even before the official market launch, we sold two VarioFill lines, the first of which will go into production at a customer’s site shortly – and more are set to follow,” says Gensheimer. Customers are particularly impressed by the modular design. “This shows that we have successfully implemented our motto ‘configure instead of construct’. Since the VarioFill platform’s design is modular from the outset, our customers can put together their individual solution to suit their production requirements – and modify or expand it flexibly at any time,” Gensheimer summarizes.

Previous Post

U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

Next Post

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

Related Posts

Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post
FDA Approves Sanofis Wayrilz

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In